Download FREE Report Sample
Download Free sampleDrug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
Drug Repositioning Market contains market size and forecasts of Drug Repositioning in Global, including the following market information:
Global Drug Repositioning Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Drug Repositioning market was valued at 27030 million in 2021 and is projected to reach US$ 36780 million by 2028, at a CAGR of 4.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Generic Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drug Repositioning include Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, Bausch Health, GSK, ChemRar Group and Glenmark, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drug Repositioning companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug Repositioning Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Drug Repositioning Market Segment Percentages, by Type, 2021 (%)
Generic Drugs
Clinical Trial Failed Drugs
Global Drug Repositioning Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Drug Repositioning Market Segment Percentages, by Application, 2021 (%)
Cardiovascular Diseases
Mental Illness
Cancer
Others
Global Drug Repositioning Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Drug Repositioning Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug Repositioning revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Drug Repositioning revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva
Novartis
Mylan
Johnson & Johnson
Pfizer
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
